News for Aurinia Pharmaceuticals Stock (AUPH)

UPCOMING AUPH DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PRNewsWire • 05/18/22

ROSEN, A Top Ranked Law Firm, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 05/16/22

Aurinia Pharmaceuticals Announces Presentations at the 2022 ERA Congress and the 2022 EULAR Congress

Business Wire • 05/16/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

PRNewsWire • 05/15/22

ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 05/14/22

INVESTOR DEADLINE: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – AUPH

Business Wire • 05/13/22

Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/11/22

Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2022 Results - Earnings Call Transcript

Seeking Alpha • 05/10/22

Aurinia Reports First Quarter 2022 Financial and Operational Results

Business Wire • 05/10/22

AUPH NOTICE: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 05/09/22

Shareholder Action Alert: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/09/22

Notice of New Dial-In Numbers for Aurinia Pharmaceuticals First Quarter 2022 Financial and Operational Results on May 10, 2022

Business Wire • 05/06/22

AUPH LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Aurinia Pharmaceuticals Inc.

Newsfile Corp • 05/04/22

Investor Action Alert: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 05/04/22

ROSEN, A TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 05/03/22

Aurinia Pharmaceuticals to Release First Quarter 2022 Financial and Operational Results on May 10, 2022

Business Wire • 05/02/22

3 Healthcare Companies With Revenue Spiking 100% or More

The Motley Fool • 05/02/22

ROSEN, Leading Investor Counsel, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 05/02/22

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

PRNewsWire • 04/30/22

Aurinia Pharmaceuticals (AUPH) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks Investment Research • 04/28/22

Investor Action Reminder: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 04/28/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 04/27/22

AUPH Stock News: Robbins LLP Investigates Aurinia Pharmaceuticals Inc. (AUPH) on Behalf of Shareholders

Business Wire • 04/26/22

AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH

Newsfile Corp • 04/25/22

INVESTOR ALERT: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AUPH

PRNewsWire • 04/23/22